RevOpsis Therapeutics
RevOpsis Therapeutics has directed its efforts towards addressing vision loss. By utilizing their exclusive bispecific Surrobody platform, the company aims to target a diverse range of ocular conditions with potential therapeutic agents. The company was founded in 2022 and is based in Springfield, Illinois, United States.
revopsis.comCompany Details
Founded
- 2022
Employees
- Between 2 - 10 employees
Raised
- $24,395,004
Public
- No
Acquired
- No
CEO
Ramanath Bhandari
Founders
- Jeff OlsonRamanath Bhandari
Company Collections
These are collections RevOpsis Therapeutics is a part of. Click on the collection name to view similar companies.